can i get tirzepatide in canada B.C. limits sale of 2 more diabetes drugs used for weight loss Health Canada has approved the

In semaglutides case: Novo Nordisk obtained a genus patent covering semaglutide as a compound, with the usual 20year protection.[19][20] Later, it filed a second patent on a closely related version intended to prolong exclusivity, along with a series of secondary patents on formulations and delivery devices.[21][14] The Delhi High Court, examining Novos suit against Indian companies like Dr Reddys, held that this second patent amounted to double patenting and evergreening , which is barred under Indias Patents Act (Section 3(d)).[20][22][19] Because India explicitly prohibits evergreening, the court refused to block Indian firms from manufacturing and exporting semaglutide while maintaining restrictions on incountry sales tied to remaining patent issues.[23][20] Key point: Courts in India have openly described parts of Novos semaglutide strategy as evergreeningextending monopoly protection beyond what a single invention normally deserves

M.AdamoskiD.Ornitz Oliveira SouzaR.Rodrigues AscenoC

Read more about Google Fonts Sharing of data For more information, please read on Google Fonts Privacy Statement

doi: 10.1007/s00726-017-2494-2, 31